โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Medicines: 15 in last 7 days ๐ŸŽ Food: 1 in last 7 days ๐Ÿงธ Products: 52 in last 7 days ๐ŸŸข Monitoring: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Last fetch: 3 hours ago โš  LIVE โ€” European Consumer Safety Watch ๐Ÿ’Š Medicines: 15 in last 7 days ๐ŸŽ Food: 1 in last 7 days ๐Ÿงธ Products: 52 in last 7 days ๐ŸŸข Monitoring: EMA ยท RASFF ยท NVWA ยท FAGG ยท FAVV ยท EFSA ยท Safety Gate โฑ Last fetch: 3 hours ago
๐Ÿ›ก๏ธ EUSW
๐Ÿ’Š Medicines ๐ŸŽ Food ๐Ÿงธ Products ๐Ÿ”Ž Search
๐Ÿ“Š Data
๐Ÿท Brands ๐ŸŒ Countries โ„น๏ธ About โœ‰ Unsubscribe
๐Ÿ‡ฌ๐Ÿ‡ง
๐Ÿ‡ฌ๐Ÿ‡ง English ๐Ÿ‡ณ๐Ÿ‡ฑ Nederlands ๐Ÿ‡ซ๐Ÿ‡ท Franรงais ๐Ÿ‡ฉ๐Ÿ‡ช Deutsch ๐Ÿ‡ช๐Ÿ‡ธ Espaรฑol ๐Ÿ‡ฎ๐Ÿ‡น Italiano ๐Ÿ‡ต๐Ÿ‡น Portuguรชs ๐Ÿ‡ต๐Ÿ‡ฑ Polski ๐Ÿ‡ธ๐Ÿ‡ช Svenska ๐Ÿ‡ท๐Ÿ‡ด Romรขnฤƒ ๐Ÿ‡จ๐Ÿ‡ฟ ฤŒeลกtina ๐Ÿ‡ซ๐Ÿ‡ฎ Suomi ๐Ÿ‡ฉ๐Ÿ‡ฐ Dansk
๐Ÿ’Š

Adakveo

crizanlizumab
Anemia, Sickle Cell
โ„น๏ธ Revoked
โœ…
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.

What it's used for

Adakveo is indicated for the prevention of recurrent vaso occlusive crises (VOCs) in sickle cell disease patients aged 16 years and older. It can be given as an add on therapy to hydroxyurea/hydroxycarbamide (HU/HC) or as monotherapy in patients for whom HU/HC is inappropriate or inadequate.

โš ๏ธ Patient safety

No

Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/adakveo
โš ๏ธ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.